GEODE CAPITAL MANAGEMENT, LLC

Position in NGNE — Neurogene Inc.

CIK 1214717 BOSTON, MA

Position in NGNE

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$9,220,573

+$3,595,873 QoQ

Shares Held

293,182

+5.1% QoQ

Ownership

1.47%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#17

of 111 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. NGNE ranks #196 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,220,573	293,182	+5.1%	Shares	Defined	2026-08-12
2026-03-31	$5,624,700	279,003	+11.7%	Shares	Defined	2026-05-15
2025-12-31	$5,143,717	249,695	+1.3%	Shares	Defined	2026-02-09
2025-09-30	$4,270,683	246,433	-0.5%	Shares	Defined	2025-11-12
2025-06-30	$3,704,236	247,775	-4.5%	Shares	Defined	2025-08-08
2025-03-31	$3,037,292	259,376	+10.5%	Shares	Defined	2025-05-13
2024-12-31	$5,363,526	234,625	+6.4%	Shares	Defined	2025-02-12
2024-09-30	$9,256,333	220,599	-0.7%	Shares	Defined	2024-11-12
2024-06-30	$8,080,836	222,062	+123.6%	Shares	Defined	2024-08-09
2024-03-31	$5,055,082	99,314	+531.8%	Shares	Defined	2024-05-13
2023-12-31	$304,634	15,719	—	Shares	Defined	2024-02-13
2023-09-30 NLTX	—	62,885	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.